Pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases veterinary pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases in domestic pets, live-stock, poultry, amphibians, teleosts and insects preparations for healthcare, namely, dietetic products for medical purposes in the nature of dietary supplements, diet pills, dietary drink mix for use as a meal replacement, dietary food supplements, food for medically restricted diets, and meal replacement barsĮducational services, namely, conducting seminars, lectures, academies, colloquiums, conferences, congresses, symposiums, workshops, practical training, in the field of molecular biology, genetic engineering, and molecular diagnostics Trademark is used in the following business:Ĭhemicals, namely, biochemical and molecular biological products for use in manufacture of pharmaceutical and veterinary pharmaceutical preparations for the diagnosis and therapy of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases chemicals, namely, biochemical products and molecular biological products in the nature of nucleic acid probes and antibodies for the detection of degenerative diseases of the central nervous system, the eye, vasculature, and for the detection of autoimmune diseases for scientific use The current status of the LYNKEUS BIOTECH filing isĬONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE.īased on LYNKEUS BioTech GmbH, the LYNKEUS BIOTECH The legal correspondent for LYNKEUS BIOTECH trademark is The LYNKEUS BIOTECH mark is filed in the category ofĬomputer & Software Services & Scientific Services The LYNKEUS BIOTECH trademark was assigned a Serial Number # 76412499 – by the United States Patent and Trademark Office (USPTO).Īssigned Trademark Serial Number is a Unique ID to identify the LYNKEUS BIOTECH trademark application in the USPTO. In total, over 300 biologists, engineers, MTAs and CTAs work at three sites in Jena and Halle (Germany) and Amsterdam (the Netherlands).Facebook Twitter Google + LinkedIn Pinterest Email Share. The WACKER subsidiary currently employees around 100 employees at its Jena headquarters. Wacker Biotech’s clients include well-known pharmaceutical and biotech firms that appreciate the company’s expertise and proprietary technologies. In 2018, €2.5 million was invested in, among other things, a fully automated fermentation plant including a new bioreactor, a new separator for efficiently isolating cells and a new GMP (Good Manufacturing Practice) cell-bank suite. To this day, the WACKER subsidiary maintains close ties to the research centers there. For a long time, Wacker Biotech was the only company on Beutenberg Campus. Wacker Biotech is now a leader in this sector. With Wacker Biotech GmbH, WACKER FINE CHEMICALS (today’s WACKER BIOSOLUTIONS) took a decisive step toward transforming its existing pharmaceutical contract-manufacturing business into the contract-development and manufacturing of therapeutic proteins. WACKER acquired this promising start-up on January 1, 2005. In 1999, the renowned Hans Knöll Institute spun off ProThera GmbH, a company specializing in the commercial development and production of biopharmaceuticals. Jena’s Beutenberg Science Campus has long been a center of research into the biotechnological production of recombinant pharmaceutical proteins. So, it was not by chance that the Munich-based chemical company WACKER decided in 2003 to locate its planned biologics activities in Jena. This unique network plays a key role in establishing and enhancing Jena’s reputation as a high-tech and biotech cluster. Industry and science collaborate here very closely. Over the years, major German research centers – such as the Max Planck, Fraunhofer and Leibniz institutes – and an array of biotech and medical-engineering firms have set up in Jena. The university city of Jena is one of Germany’s main biotech centers.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |